Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Image Interpretation, Computer-Assisted | 13 | 2020 | 3390 | 1.310 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2025 | 359 | 1.240 |
Why?
|
| Brain | 24 | 2025 | 27362 | 1.140 |
Why?
|
| Magnetic Resonance Imaging | 28 | 2025 | 36741 | 1.110 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2022 | 9016 | 0.940 |
Why?
|
| Pattern Recognition, Automated | 9 | 2017 | 993 | 0.920 |
Why?
|
| Algorithms | 20 | 2022 | 14164 | 0.780 |
Why?
|
| Subtraction Technique | 6 | 2014 | 517 | 0.770 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 46 | 0.730 |
Why?
|
| Intelligence | 1 | 2024 | 926 | 0.660 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 290 | 0.580 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 395 | 0.540 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2018 | 2815 | 0.540 |
Why?
|
| Breast Feeding | 2 | 2022 | 1363 | 0.490 |
Why?
|
| Imaging, Three-Dimensional | 8 | 2019 | 4064 | 0.470 |
Why?
|
| Child Development | 3 | 2023 | 2330 | 0.470 |
Why?
|
| Myelin Sheath | 3 | 2024 | 652 | 0.450 |
Why?
|
| Infant, Newborn | 14 | 2025 | 26421 | 0.440 |
Why?
|
| Longevity | 1 | 2021 | 1077 | 0.430 |
Why?
|
| Brain Mapping | 6 | 2022 | 6684 | 0.410 |
Why?
|
| Infant | 17 | 2023 | 36535 | 0.360 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 1399 | 0.360 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2020 | 1399 | 0.350 |
Why?
|
| Image Enhancement | 8 | 2014 | 2880 | 0.350 |
Why?
|
| Brain Injuries | 2 | 2025 | 2057 | 0.350 |
Why?
|
| Dyslexia | 2 | 2022 | 215 | 0.330 |
Why?
|
| Databases, Factual | 5 | 2020 | 8080 | 0.330 |
Why?
|
| Ultrasonography | 2 | 2019 | 6004 | 0.320 |
Why?
|
| Sturge-Weber Syndrome | 2 | 2022 | 89 | 0.320 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2014 | 640 | 0.310 |
Why?
|
| Atlases as Topic | 4 | 2020 | 248 | 0.300 |
Why?
|
| Health Services Research | 1 | 2014 | 1815 | 0.270 |
Why?
|
| Brain Neoplasms | 6 | 2019 | 9118 | 0.260 |
Why?
|
| Artificial Intelligence | 4 | 2012 | 2666 | 0.240 |
Why?
|
| Lutein | 2 | 2022 | 123 | 0.240 |
Why?
|
| Preoperative Care | 1 | 2014 | 2258 | 0.240 |
Why?
|
| Child, Preschool | 9 | 2022 | 42669 | 0.240 |
Why?
|
| Autistic Disorder | 2 | 2024 | 1240 | 0.240 |
Why?
|
| Child | 15 | 2024 | 80917 | 0.230 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 1623 | 0.230 |
Why?
|
| Intelligence Tests | 1 | 2024 | 504 | 0.220 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2017 | 1091 | 0.210 |
Why?
|
| Humans | 55 | 2025 | 768171 | 0.200 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2019 | 1003 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 16044 | 0.190 |
Why?
|
| Mathematical Concepts | 1 | 2020 | 75 | 0.170 |
Why?
|
| Cytogenetic Analysis | 1 | 2021 | 271 | 0.170 |
Why?
|
| Reading | 2 | 2022 | 543 | 0.170 |
Why?
|
| Young Adult | 8 | 2024 | 60066 | 0.170 |
Why?
|
| Lactation | 1 | 2021 | 392 | 0.160 |
Why?
|
| Seizures | 3 | 2022 | 2998 | 0.160 |
Why?
|
| Carotenoids | 1 | 2021 | 620 | 0.160 |
Why?
|
| Mothers | 3 | 2023 | 2209 | 0.150 |
Why?
|
| Adult | 15 | 2024 | 223646 | 0.150 |
Why?
|
| Reproducibility of Results | 11 | 2015 | 20225 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 2420 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2021 | 1489 | 0.150 |
Why?
|
| Software | 3 | 2021 | 4480 | 0.150 |
Why?
|
| Sensitivity and Specificity | 9 | 2014 | 14729 | 0.140 |
Why?
|
| Prostatic Neoplasms | 4 | 2017 | 11101 | 0.130 |
Why?
|
| Adolescent | 7 | 2024 | 89169 | 0.130 |
Why?
|
| Anatomy, Artistic | 1 | 2015 | 51 | 0.130 |
Why?
|
| Adrenoleukodystrophy | 1 | 2017 | 144 | 0.130 |
Why?
|
| Hydrocortisone | 1 | 2023 | 1841 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7477 | 0.120 |
Why?
|
| Female | 24 | 2024 | 397187 | 0.120 |
Why?
|
| Organ Size | 1 | 2020 | 2267 | 0.120 |
Why?
|
| Probability | 1 | 2019 | 2479 | 0.110 |
Why?
|
| Child Abuse | 1 | 2023 | 1091 | 0.110 |
Why?
|
| Skull | 1 | 2018 | 829 | 0.110 |
Why?
|
| Middle Aged | 11 | 2024 | 223487 | 0.110 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2017 | 282 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 937 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 22371 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 531 | 0.110 |
Why?
|
| Nutritional Status | 1 | 2021 | 1628 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 662 | 0.110 |
Why?
|
| Microcirculation | 1 | 2017 | 1281 | 0.100 |
Why?
|
| Male | 22 | 2024 | 364731 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2018 | 3464 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2017 | 709 | 0.100 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 8759 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 59626 | 0.100 |
Why?
|
| Boston | 1 | 2025 | 9374 | 0.100 |
Why?
|
| Aged | 8 | 2022 | 171502 | 0.100 |
Why?
|
| Prospective Studies | 7 | 2024 | 54924 | 0.090 |
Why?
|
| Quinolines | 1 | 2016 | 772 | 0.090 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 823 | 0.090 |
Why?
|
| Taxoids | 1 | 2014 | 667 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3782 | 0.090 |
Why?
|
| Tetralogy of Fallot | 2 | 2017 | 628 | 0.090 |
Why?
|
| Attention | 1 | 2021 | 2423 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2022 | 2062 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2022 | 41753 | 0.080 |
Why?
|
| Prostate | 1 | 2017 | 1765 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2227 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2077 | 0.080 |
Why?
|
| Computational Biology | 1 | 2020 | 3567 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1461 | 0.070 |
Why?
|
| China | 1 | 2014 | 2395 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2014 | 2234 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 21207 | 0.070 |
Why?
|
| Heart Ventricles | 2 | 2017 | 3841 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3948 | 0.060 |
Why?
|
| Contrast Media | 2 | 2018 | 5330 | 0.060 |
Why?
|
| Prognosis | 3 | 2021 | 30009 | 0.060 |
Why?
|
| Atrophy | 2 | 2024 | 1646 | 0.060 |
Why?
|
| Reference Standards | 2 | 2021 | 1014 | 0.060 |
Why?
|
| Age Factors | 1 | 2020 | 18415 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2235 | 0.050 |
Why?
|
| Diet | 1 | 2021 | 8089 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8052 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 2145 | 0.050 |
Why?
|
| Population | 2 | 2014 | 141 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 2907 | 0.050 |
Why?
|
| Consultants | 1 | 2022 | 57 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39354 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 65379 | 0.050 |
Why?
|
| Photometry | 1 | 2021 | 57 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2022 | 127 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13586 | 0.050 |
Why?
|
| Pregnancy | 2 | 2022 | 30255 | 0.050 |
Why?
|
| Maternal Behavior | 1 | 2023 | 307 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2017 | 1643 | 0.040 |
Why?
|
| Hippocampus | 2 | 2023 | 3783 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 9419 | 0.040 |
Why?
|
| Clavicle | 1 | 2022 | 224 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2024 | 81760 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4887 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26379 | 0.040 |
Why?
|
| Motor Skills | 1 | 2022 | 523 | 0.040 |
Why?
|
| Lung | 1 | 2017 | 10101 | 0.040 |
Why?
|
| Language Development | 1 | 2020 | 183 | 0.040 |
Why?
|
| Artifacts | 2 | 2020 | 1926 | 0.040 |
Why?
|
| Hemizygote | 1 | 2017 | 27 | 0.040 |
Why?
|
| Radiography | 2 | 2022 | 6986 | 0.040 |
Why?
|
| Milk, Human | 1 | 2021 | 490 | 0.040 |
Why?
|
| Social Behavior | 1 | 2023 | 1147 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2014 | 5130 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2021 | 752 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 4818 | 0.030 |
Why?
|
| Biopsy | 1 | 2007 | 6792 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 726 | 0.030 |
Why?
|
| Cerebral Cortex | 2 | 2023 | 5812 | 0.030 |
Why?
|
| Amygdala | 1 | 2023 | 1379 | 0.030 |
Why?
|
| ROC Curve | 2 | 2013 | 3628 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2018 | 614 | 0.030 |
Why?
|
| Water | 1 | 2021 | 1421 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 590 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20762 | 0.030 |
Why?
|
| Metabolome | 1 | 2021 | 1009 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2012 | 6983 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13677 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11878 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6029 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 1035 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 1429 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14783 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 963 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 3533 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 3556 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 18065 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8741 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 4034 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1524 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 2725 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 2631 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1988 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2012 | 1649 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12840 | 0.010 |
Why?
|
| Glioma | 1 | 2019 | 3503 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10099 | 0.010 |
Why?
|
| Gadolinium | 1 | 2008 | 964 | 0.010 |
Why?
|
| tau Proteins | 1 | 2013 | 2144 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13290 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 13013 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 82049 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8743 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5151 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 7140 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2013 | 3914 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22290 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5717 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3081 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 13045 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 169285 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13668 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15453 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 30237 | 0.010 |
Why?
|
Concepts
(189)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_